Literature DB >> 26302408

Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis.

Simone Cardaci1, Liang Zheng1, Gillian MacKay1, Niels J F van den Broek1, Elaine D MacKenzie1, Colin Nixon1, David Stevenson1, Sergey Tumanov1,2, Vinay Bulusu1,2, Jurre J Kamphorst1,2, Alexei Vazquez1, Stewart Fleming3, Francesca Schiavi4, Gabriela Kalna1, Karen Blyth1, Douglas Strathdee1, Eyal Gottlieb1.   

Abstract

Succinate dehydrogenase (SDH) is a heterotetrameric nuclear-encoded complex responsible for the oxidation of succinate to fumarate in the tricarboxylic acid cycle. Loss-of-function mutations in any of the SDH genes are associated with cancer formation. However, the impact of SDH loss on cell metabolism and the mechanisms enabling growth of SDH-defective cells are largely unknown. Here, we generated Sdhb-ablated kidney mouse cells and used comparative metabolomics and stable-isotope-labelling approaches to identify nutritional requirements and metabolic adaptations to SDH loss. We found that lack of SDH activity commits cells to consume extracellular pyruvate, which sustains Warburg-like bioenergetic features. We further demonstrated that pyruvate carboxylation diverts glucose-derived carbons into aspartate biosynthesis, thus sustaining cell growth. By identifying pyruvate carboxylase as essential for the proliferation and tumorigenic capacity of SDH-deficient cells, this study revealed a metabolic vulnerability for potential future treatment of SDH-associated malignancies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26302408      PMCID: PMC4591470          DOI: 10.1038/ncb3233

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  29 in total

1.  Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

Authors:  Andrew R Mullen; Zeping Hu; Xiaolei Shi; Lei Jiang; Lindsey K Boroughs; Zoltan Kovacs; Richard Boriack; Dinesh Rakheja; Lucas B Sullivan; W Marston Linehan; Navdeep S Chandel; Ralph J DeBerardinis
Journal:  Cell Rep       Date:  2014-05-22       Impact factor: 9.423

2.  Pyruvate carboxylase is required for glutamine-independent growth of tumor cells.

Authors:  Tzuling Cheng; Jessica Sudderth; Chendong Yang; Andrew R Mullen; Eunsook S Jin; José M Matés; Ralph J DeBerardinis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

3.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.

Authors:  B E Baysal; J E Willett-Brozick; E C Lawrence; C M Drovdlic; S A Savul; D R McLeod; H A Yee; D E Brackmann; W H Slattery; E N Myers; R E Ferrell; W S Rubinstein
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

4.  Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Authors:  Sakari Vanharanta; Mary Buchta; Sarah R McWhinney; Sanna K Virta; Mariola Peçzkowska; Carl D Morrison; Rainer Lehtonen; Andrzej Januszewicz; Heikki Järvinen; Matti Juhola; Jukka-Pekka Mecklin; Eero Pukkala; Riitta Herva; Maija Kiuru; Nina N Nupponen; Lauri A Aaltonen; Hartmut P H Neumann; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

5.  Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.

Authors:  Ying Ni; Kevin M Zbuk; Tammy Sadler; Attila Patocs; Glenn Lobo; Emily Edelman; Petra Platzer; Mohammed S Orloff; Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2008-08       Impact factor: 11.025

6.  Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.

Authors:  Robert D Guzy; Bhumika Sharma; Eric Bell; Navdeep S Chandel; Paul T Schumacker
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

7.  Germline SDHB mutations and familial renal cell carcinoma.

Authors:  Christopher Ricketts; Emma R Woodward; Pip Killick; Mark R Morris; Dewi Astuti; Farida Latif; Eamonn R Maher
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

8.  Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.

Authors:  Christopher J Ricketts; Brian Shuch; Cathy D Vocke; Adam R Metwalli; Gennady Bratslavsky; Lindsay Middelton; Youfeng Yang; Ming-Hui Wei; Stephen E Pautler; James Peterson; Catherine A Stolle; Berton Zbar; Maria J Merino; Laura S Schmidt; Peter A Pinto; Ramaprasad Srinivasan; Karel Pacak; W Marston Linehan
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

9.  Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma.

Authors:  Youfeng Yang; Andrew N Lane; Christopher J Ricketts; Carole Sourbier; Ming-Hui Wei; Brian Shuch; Lisa Pike; Min Wu; Tracey A Rouault; Laszlo G Boros; Teresa W-M Fan; W Marston Linehan
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

10.  Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.

Authors:  Jose L Izquierdo-Garcia; Larry M Cai; Myriam M Chaumeil; Pia Eriksson; Aaron E Robinson; Russell O Pieper; Joanna J Phillips; Sabrina M Ronen
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

View more
  106 in total

1.  Rethinking glutamine addiction.

Authors:  Abigail S Krall; Heather R Christofk
Journal:  Nat Cell Biol       Date:  2015-12       Impact factor: 28.824

2.  Aerobic Glycolysis and the Warburg Effect. An Unexplored Realm in the Search for Fibrosis Therapies?

Authors:  Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

3.  Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells.

Authors:  Susan Richter; Vanessa D'Antongiovanni; Serena Martinelli; Nicole Bechmann; Maria Riverso; David M Poitz; Karel Pacak; Graeme Eisenhofer; Massimo Mannelli; Elena Rapizzi
Journal:  Cell Tissue Res       Date:  2018-08-29       Impact factor: 5.249

Review 4.  Mitochondrial Complex II: At the Crossroads.

Authors:  Ayenachew Bezawork-Geleta; Jakub Rohlena; Lanfeng Dong; Karel Pacak; Jiri Neuzil
Journal:  Trends Biochem Sci       Date:  2017-02-07       Impact factor: 13.807

Review 5.  Mitochondrial Metabolism as a Target for Cancer Therapy.

Authors:  Karthik Vasan; Marie Werner; Navdeep S Chandel
Journal:  Cell Metab       Date:  2020-07-14       Impact factor: 27.287

Review 6.  Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Authors:  Pushpa Neppala; Sudeep Banerjee; Paul T Fanta; Mayra Yerba; Kevin A Porras; Adam M Burgoyne; Jason K Sicklick
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

Review 7.  Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Buffet; Aurélie Morin; Judith Goncalves; Judith Favier
Journal:  Cell Tissue Res       Date:  2018-02-09       Impact factor: 5.249

Review 8.  New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.

Authors:  David Taïeb; Karel Pacak
Journal:  Trends Endocrinol Metab       Date:  2017-08-31       Impact factor: 12.015

Review 9.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

10.  Absolute Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial Metabolism.

Authors:  Walter W Chen; Elizaveta Freinkman; Tim Wang; Kıvanç Birsoy; David M Sabatini
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.